Genetic study for hepatitis B patients to find new treatment pathways
Part of Digestive system, Infections clinical trials.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have chronic hepatitis B, with or without treatment
- You are willing to give a blood sample and sign a consent form
- You do not have other serious liver diseases like hepatitis C, HIV, or obesity-related liver disease
- You do not have an autoimmune disease or cancer
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a group of people to measure small hepatitis B “viral RNA” signals in the blood. The goal is to see if these measurements could help researchers find a functional cure and better understand who may respond over time.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
This study looks at new blood tests (biomarkers) to better understand chronic hepatitis B and how it affects treatment decisions. It may help doctors find better ways to manage your condition.
This trial tests a gene therapy called PBGENE-HBV for people with chronic hepatitis B who are already on antiviral treatment. The goal is to see if it is safe and can help control the virus.
This study looks at how treating chronic hepatitis B affects people's daily lives, not just their liver health. It aims to understand the good and bad impacts from a patient's perspective.
This study looks at genetic factors that may help people with chronic hepatitis B achieve a clinical cure when treated with long-acting interferon. It aims to find out why some patients respond better than others.
Hear when a new Chronic Hepatitis B Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.